This new version of GeMTC includes the initial version of a new algorithm for generating node-splitting models. In addition, it was completely rewritten in Java for easier maintenance and to make the source accessible to a wider audience of developers. This also reduces the download size by 5 MB.
ADDIS v1.12.2 fixes an error in the captions of the "Lynd and O'Brien" plots and stops the back-button in the network meta-analysis wizard from resetting the selected drugs.
ADDIS v1.12.1 improves usability by consistently asking the user to create a name for analyses in the first step of the wizard.
TI Pharma has approved a commissioned project, in which both the ADDIS software itself and the ADDIS data model will be evaluated by industry experts. Hans van Leeuwen will conduct a series of interviews with various pharmaceutical companies, and Jos Aerts will evaluate the data model. See the summary of the proposal for more information.
We are happy to announce the release of ADDIS v1.12. This new release introduces BRAT framework benefit-risk assessment and several improvements in performance and usability.
